SYSTEMATIC REVIEW article
Systematic Review on Fractal Dimension of the Retinal Vasculature in Neurodegeneration and Stroke: Assessment of a Potential Biomarker
- 1Department of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium
- 2Research Group Ophthalmology, Biomedical Science Group, Department of Neurosciences, KU Leuven, Leuven, Belgium
- 3Health Unit, VITO (Flemish Institute for Technological Research), Mol, Belgium
- 4Centre of Environmental Sciences, Hasselt University, Diepenbeek, Belgium
Introduction: Ocular manifestations in several neurological pathologies accentuate the strong relationship between the eye and the brain. Retinal alterations in particular can serve as surrogates for cerebral changes. Offering a “window to the brain,” the transparent eye enables non-invasive imaging of these changes in retinal structure and vasculature. Fractal dimension (FD) reflects the overall complexity of the retinal vasculature. Changes in FD could reflect subtle changes in the cerebral vasculature that correspond to preclinical stages of neurodegenerative diseases. In this review, the potential of this retinal vessel metric to serve as a biomarker in neurodegeneration and stroke will be explored.
Methods: A literature search was conducted, following the PRISMA Statement 2009 criteria, in four large bibliographic databases (Pubmed, Embase, Web Of Science and Cochrane Library) up to 12 October 2019. Articles have been included based upon their relevance. Wherever possible, level of evidence (LOE) has been assessed by means of the Oxford Centre for Evidence-based Medicine Level of Evidence classification.
Results: Twenty-one studies were included for qualitative synthesis. We performed a narrative synthesis and produced summary tables of findings of included papers because methodological heterogeneity precluded a meta-analysis. A significant association was found between decreased FD and neurodegenerative disease, mainly addressing cognitive impairment (CI) and dementia. In acute, subacute as well as chronic settings, decreased FD seems to be associated with stroke. Differences in FD between subtypes of ischemic stroke remain unclear.
Conclusions: This review provides a summary of the scientific literature regarding the association between retinal FD and neurodegenerative disease and stroke. Central pathology is associated with a decreased FD, as a measure of microvascular network complexity. As retinal FD reflects the global integrity of the cerebral microvasculature, it is an attractive parameter to explore. Despite obvious concerns, mainly due to a lack of methodological standardization, retinal FD remains a promising non-invasive and low-cost diagnostic biomarker for neurodegenerative and cerebrovascular disease. Before FD can be implemented in clinic as a diagnostic biomarker, the research community should strive for uniformization and standardization.
The retina and optic nerve are outgrowths of the embryonic diencephalon and therefore share anatomic similarities, and functional and immunological characteristics with the brain (London et al., 2013; De Groef and Cordeiro, 2018). Hence, the retina can be approached as an integral part of the central nervous system. The occurrence of ocular manifestations in neurodegenerative and cerebrovascular pathologies, such as Alzheimer's disease (AD), Parkinson's disease (PD) and stroke, accentuates the strong relationship between the eye and the brain (Archibald et al., 2009; Armstrong, 2015; Lim et al., 2016; Cheung et al., 2017; Mahajan and Votruba, 2017). Retinal changes in particular can present a surrogate for cerebral changes in these disorders. Offering a “window to the brain,” the transparent eye enables non-invasive imaging of these changes in retinal structure and vasculature.
Microvascular changes are an important component of neurodegenerative and cerebrovascular diseases (Iadecola, 2010; Brown and Thore, 2011; Wardlaw et al., 2013; Shi and Wardlaw, 2016). The presence of a retinal counterpart of these vascular changes has been reported repeatedly (Patton et al., 2007; Frost et al., 2013; Cheung et al., 2019). Fundus photography is a routine analysis to visualize retinopathy signs (retinal hemorrhage, microaneurysms) and retinal vascular caliber changes, which have been shown to be associated with these disorders of the central nervous system. Central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE) quantify generalized retinal vessel narrowing or widening, matching subtle dysfunction of the retinal microvasculature. Decreased CRVE and CRAE have been associated with AD (Frost et al., 2013; Cheung et al., 2014b). But the retinal vascular tree holds more information than these focal measurements, and advances in retinal imaging and (semi-)automated image processing and analysis rose scientific interest in the association between retinal vessel metrics such as the fractal dimension (FD), tortuosity and branching of the retinal vascular network and neurodegenerative and cerebrovascular disorders. These retinal vascular network parameters quantify global vessel network characteristics, reflecting the integrity of the cerebral microcirculation (Cheung et al., 2015).
The FD of the retinal vascular network is a relatively novel parameter, introduced by Mandelbrot and Wheeler (1983) that has already been described in many subfields of medicine (Mandelbrot and Wheeler, 1983; Goldberger and West, 1987; Stanley et al., 2005). In 1990, Mainster was the first to describe the retinal microvascular network as a fractal, implying great potential to gain new insights in the complex arborization pattern of the retinal vascular network (Mainster, 1990). During the last three decades, this upcoming non-invasive parameter has proven its merits in various research papers often covering multidisciplinary research combining ophthalmology with cardiology, endocrinology, or neurology. Significant correlations with refractive error (Li et al., 2010; Al-Sheikh et al., 2017), glaucoma (Kolár and Jan, 2008; Wu et al., 2013), age-related macular degeneration (Al-Sheikh et al., 2018), cardiovascular health (Liew et al., 2008; Cheung et al., 2011) and diabetes mellitus have been reported (Avakian et al., 2002; Cheung et al., 2009). In 2019 alone, more than 20 research papers addressing the retinal FD, have been registered in MEDLINE. The FD of the retinal vascular network is a measure of its complexity and vessel density (Mainster, 1990; Misson et al., 1992; Masters, 2004; Kwa and Lopez, 2010; Ab Hamid et al., 2016). The retinal vasculature is a transport network delivering oxygen and nutrients to the retinal tissue and removing waste products. This network strives for minimal energy consumption, reflected by its accordance to Murray's Law of Minimal Work, which describes an optimal relationship between the radii of mother and daughter branches in a network. This law leads to the typical vessel arborization pattern of the retina (Rossitti, 1995). Many parameters of this vascular tree are being studied, and FD is one expressing the density and overall complexity of this spatial pattern in one number. It literally means “broken dimension.” The retinal microvasculature can be considered to be more dimensional than a line (1-dimensional), but less than a square (2-dimensional), hence a dimension between 1 and 2 can be attributed to this pattern with a higher number reflecting a more complex branching pattern. The retinal FD is associated with age (Azemin et al., 2012; Che Azemin et al., 2013; Wei et al., 2017), refractive error (Li et al., 2010, 2017; Azemin et al., 2014; Yang et al., 2016; Al-Sheikh et al., 2017; Tai et al., 2017) and comorbidities (Avakian et al., 2002; Liew et al., 2008; Cheung et al., 2009, 2011).
In our review we collect and summarize the current literature on FD measurements from studies addressing possible associations between global retinal parameters and cerebral disease, with a particular focus on dementia and stroke.
This systematic review aims to provide an overview of the current scientific evidence of changes in the FD of the retinal vasculature in subjects affected by central neurodegenerative disease or stroke.
Is the retinal FD significantly altered in patients with central neurodegenerative disease and/or stroke and to what extent can retinal FD serve as a non-invasive biomarker for these diseases?
What could be the potential future applications of retinal FD and which hurdles are still to be overcome?
We adopted the Preferred Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines (Moher et al., 2009).
We searched: MEDLINE (PubMed), EMBASE (Ovid), Web Of Science (Clarivate Analytics), and Cochrane Library (Cochrane). Search strategies were constructed using database specific subject headings and keywords. The search strategies are provided as (Supplementary Data 1). These searches were extended by hand searching the bibliographies of all included studies.
Gray literature was not considered. Accepted language of publication were: English, German, French and Dutch. Articles published until October 12, 2019 were included.
Case-control studies, cohort studies, and case series were included. Case reports, case series with < 10 patients, reviews and articles without original results were excluded.
Participants, Interventions, Comparators
We included studies on patients affected by stroke or central neurodegenerative disease.
Severity of stroke, etiology of stroke, stages of cognitive impairment (CI), or etiology of central neurodegeneration were not exclusion criteria.
We included studies using the following retinal imaging techniques:
- Conventional digital fundus photography
- Scanning laser ophthalmoscopy (SLO)
- Optical coherence tomography angiography (OCT-A).
Data Sources, Studies Sections, and Data Extraction
According to the PRISMA flow diagram, screening of titles and abstracts was carried out. Non-pertinent articles were rejected. Duplicates were removed using Mendeley Reference Manager (by Mendeley, London, UK). After this initial selection, full texts were independently judged for eligibility by three independent reviewers (SL, AD, JB) and inconsistencies were solved by consensus. We used the Oxford Centre for Evidence-based Medicine classification to determine the LOE (Phillips, 2014) of the papers included in this qualitative synthesis (Table 1).
The main outcome of this systematic review was the current understanding of changes in the FD of the retinal vasculature in central neurodegenerative disease and stroke patients. Results were separately analyzed and presented for studies addressing stroke and neurodegenerative pathology. In the subset of central neurodegeneration studies, differences between various types and stages of CI were analyzed wherever possible.
A total of 205 studies were screened using the described search strategy. At the end of the selection process, 13 case-control studies, seven cohort studies and one case series were included in the systematic review. Prisma flow diagram (Figure 1) gives details on screening process. Six out of 21 (29%) studies examined retinal vascular changes in terms of FD alone, whereas the 15 (71%) remaining studies examined at least one other vascular metric.
Figure 1. PRISMA 2009 flow diagram (Moher et al., 2009).
A total of 9,397 subjects were considered in this systematic review. Nine studies included stroke patients, 12 included neurodegeneration patients, with one of these including patients with disease overlap between stroke and neurodegeneration. Because of the clinical characteristics of the study population (CI subjects, based on Abbreviated Mental Test (AMT) score and self-report of progressive forgetfulness), this study by Hilal et al. has been included in the neurodegenerative section of this review (Hilal et al., 2014).
Regarding studies focusing on neurodegenerative disease, four included only patients with cognitive impairment no dementia (CIND), four had only patients with AD, two combined CIND as well as dementia patients, one included only patients with PD, and finally one study reported on the parameters of the retinal microvascular network and cognitive ability in physiological aging in a cohort of older adults without CI. Severity of CI with or without dementia varies from mild to severe and some authors included different stages in the same study. However, the method of severity classification was not consistent throughout all studies.
Stroke subtype was not specified in three out of eight stroke studies and in a subset of 84 out of 231 stroke patients belonging to a fourth study (the latter corresponding with 15% of the total number of stroke patients). Three studies included different types of ischemic stroke whereas two studies included lacunar stroke patients only.
Patient characteristics of included studies are reported in Table 1. Subjects included in the central neurodegeneration section of this review show heterogeneity in mean age ranging from 59 (Shi et al., 2019) up to 81 (Cabrera DeBuc et al., 2018) years. In the section dedicated to studies focusing on stroke patients, the heterogeneity in mean age is even higher, from 44 (Cavallari et al., 2011) up to 74 (Kawasaki et al., 2011). Most studies accounted for potential confounding due to age, gender and cardiovascular risk factors by multivariate regression or exclusion. The effect of refractive error and ocular comorbidities however, was rarely described, let alone taken into account in statistical analysis.
Outcomes of Fractal Analysis in Studies on Neurodegenerative Disease
Changes in the FD of the retinal vasculature in neurodegenerative disease patients are reported in Table 2. One particular methodological set-up was the strategy of choice in eight out of 13 neurodegeneration studies. These studies combined their focus on CI and/or dementia with a region of interest (ROI) of 0.5–2.0 disc diameters from the disc margin on a disc-centered fundus image, taken with a conventional 45° field-of-view (FOV) digital retinal camera and processed and analyzed using the commercially available Singapore I Vessel Assessment (SIVA, National University of Singapore, Singapore) software, offering curvature-based vessel segmentation and calculation of the FD as a monofractal using the box counting method. Seven of these papers reported a decreased FD in AD (Frost et al., 2013; Cheung et al., 2014b; Williams et al., 2015), CI (including dementia) (Cheung et al., 2014a), subcortical vascular CI (including vascular dementia) but not in CI related to AD (Jung et al., 2019), or CIND (Ong et al., 2014), as opposed to cognitively normal controls. Lower FD was also reported in cognitively impaired elderly with multiple cerebral microbleeds, as opposed to cognitively impaired elderly without multiple cerebral microbleeds (Hilal et al., 2014). Naidu et al. applied the same strategy in a population of recently diagnosed type 2 diabetics with and without CIND, but found no association between FD and cognitive status (Naidu et al., 2016). Some of the studies using this method showed an association between FD and AMT score (Cheung et al., 2014a) and cognitive performance (Ong et al., 2014), but a significant relationship between FD and Mini-Mental State Examination (MMSE) (Jung et al., 2019) or plaque burden in cognitively normal controls (Frost et al., 2013) could not be confirmed.
The five remaining studies used a different methodology. Three of these focused on CI, and even with differences in ROI, imaging device, vessel segmentation software, FD calculation method and software, all three confirmed a significant decrease of FD measures in CI (including dementia) (Cabrera DeBuc et al., 2018), mild CI (Jiang et al., 2018) and AD (Csincsik et al., 2018). After a follow-up period of 2 years, Csincsik et al. reported that the significant difference in FD between AD and controls at baseline had become a trend (Csincsik et al., 2018), whereas Jiang et al. described a trend of vascular density loss from controls over MCI to AD cases (Jiang et al., 2018). A significant association between fractal dimension and Montreal Cognitive Assessment (MoCA) could not be confirmed (Cabrera DeBuc et al., 2018).
The only study including only healthy elderly could not establish an association between FD and cognitive ability, both measured in later life. Differences in childhood cognitive ability appeared to account for much of the variance in cognitive ability in older age (Taylor et al., 2015).
Research by Shi et al., unique in its position addressing retinal microvascular changes in PD and one of two studies using OCT-A, showed that FD of the superficial vascular plexus was decreased in all analyzed regions and that FD of the deep vascular plexus was decreased in all but two ROIs. Of note, this was the only study able to confirm a significant correlation with disease duration (Shi et al., 2019).
Outcomes of Fractal Analysis in Stroke Studies
Table 3 summarizes the findings on fractal dimension analysis of the retinal vasculature in stroke patients. The eight studies that were kept for our review are heterogeneous, both in methods and in outcome. Cheung et al. and Ong et al. shared the same methodological set-up and analyzed monofractal FD in ischemic stroke patients using SIVA software. Ong et al. reported a significant association between decreased FD and acute ischemic stroke (Ong et al., 2013). Cheung et al. concluded that retinal imaging may help in the discrimination between subjects with a history with and without stroke, as well as stratification of stroke risk (Cheung et al., 2013). Two other studies confirmed a decrease in FD is associated with higher risk of stroke (Kawasaki et al., 2011; Aliahmad et al., 2014). It has to be noted that both studies analyzed data from subsets of the same Blue Mountains Eye Study (BMES) cohort, with the stroke cases included by Aliahmad et al. all being part of those included by Kawasaki et al.
In acute and subacute setting, studies reported decreased microvascular network complexity in lacunar stroke compared to mild cortical stroke (Doubal et al., 2010), an association between a decrease in arteriolar FD and deep white matter hyperintensity (WMH) scores in patients with a recent lacunar or cortical stroke (McGrory et al., 2019), and a general decrease in FD in ischemic stroke compared to controls without stroke (Ong et al., 2013). In contrast, Cheung et al. showed an increased FD in patients with acute lacunar stroke compared to patients with other types of acute ischemic stroke (Cheung et al., 2010).
The only case series included in this review studied retinal microvascular complexity in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and the authors concluded that vascular complexity was decreased but they failed to reveal a correlation with disease duration or lesion volume on magnetic resonance imaging (Cavallari et al., 2011).
In this review, the outcomes of fractal analysis in neurodegeneration studies show a decreased FD in various degrees and etiologies of CI, including AD and vascular dementia, as opposed to cognitively normal controls. Despite rather small sample sizes, findings are consistent with effect sizes ranging from −0.018 (Csincsik et al., 2018) to −1.33 (Cabrera DeBuc et al., 2018). The findings in studies with stroke patients are less straightforward, probably due to the heterogeneity in both study design and methodological set-up. Overall, in acute, subacute as well as in chronic settings, decreased FD seems to be associated with stroke. Differences in FD between subtypes of ischemic stroke remain unclear. The most striking inconsistency arose from two papers by Cheung et al. and Doubal et al., both focusing on FD in lacunar stroke vs. non-lacunar stroke (Cheung et al., 2010; Doubal et al., 2010). Cheung et al. reported an increased FD in lacunar stroke compared to other stroke types, whereas Doubal et al. observed a decreased FD in lacunar stroke compared to mild cortical stroke. More recent findings by McGrory et al. (2019), reporting an association between sparser arteriolar retinal network and cerebral small vessel disease, favor those by Doubal et al.
Potential Clinical Value of Retinal Fractal Dimension in Central Neurodegeneration and Stroke
Interesting observations are being made with retinal fractal dimension. However, a number of methodological issues need to be addressed before the metric can be considered for clinical application as a reliable and non-invasive biomarker in central neurodegeneration and/or stroke. Indeed, some hurdles remain to be taken, such as uniformization of patient populations and study design. First of all, study populations were generally well characterized but heterogeneous throughout studies (e.g., ethnicity) and overall of fairly small size. Work by Cheung et al., Ong et al., McGrory et al., and Williams et al. comprised larger population samples (Cheung et al., 2013, 2014a; Ong et al., 2013; Taylor et al., 2015; Williams et al., 2015; McGrory et al., 2019). In studies focusing on cognitive dysfunction, the standardized National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria were mostly applied for AD diagnosis, but the assessment of healthy cognitive status or CI (stage not specified) was based on a variety of tests and criteria, often complemented by brain imaging. Comparable to the importance of etiology and disease staging in CI and dementia studies, it is equally important in stroke studies to differentiate between different stroke subtypes and acute vs. chronic setting. Second, many different methodological set-ups have been implemented. Imaging devices considered mainly conventional digital retinal cameras, but the latest studies already made the first steps toward ultra-widefield SLO and OCT-A. The most often demarcated ROI, being the annulus between 0.5 and 2.0 disc diameters from the disc margin, originated from the Atherosclerosis Risk in Communities (ARIC) cohort and has been developed for use with Canon 45° retinal photographs (modified ARIC grid) (Hubbard et al., 1999). The use of a particular ROI was not well-argumented in any of the studies. Vessel segmentation was usually done semi-automatically, using custom or commercially available software packages. Agreement between different software packages appears to be poor (McGrory et al., 2018). Huang et al. showed an important effect of vessel annotations from human observers, automatic segmentation methods, various regions of interest, accuracy of vessel segmentation methods, and different imaging modalities on FD measurement, suggesting FD must be determined under very strict conditions to deliver a stable parameter (Huang et al., 2016). After image processing, automated FD calculation was performed. The FD can be determined in a monofractal or multifractal approach. The monofractal FD is a constant for all scales, whereas the multifractal FDq describes the multifractal behavior of a structure in different scales. Monofractal FD can be calculated using Higuchi's method, using a spectrum or Fourier method, or using a box counting method. Multifractal FD comprises FD0, FD1, and FD2: capacity dimension, entropy dimension and correlation dimension, respectively. Because of its degree of spatial complexity, the retinal arteriolar tree may represent a composite of many monofractal dimensions, making a multifractal technique better suited to characterize such arrangement (Stosić and Stosić, 2006). The monofractal dimension was usually calculated using the box counting method. The only paper calculating monofractal dimension using all three techniques, however, identified Higuchi's FD as a better predictor of stroke (Aliahmad et al., 2014). The three papers using a multifractal approach applied the generalized sandbox method (Doubal et al., 2010; Taylor et al., 2015; Cabrera DeBuc et al., 2018). According to Doubal et al., FD0 would be the most appropriate measure for the complexity of the retinal microvasculature, because it appeared most sensitive to small vascular changes (Doubal et al., 2010). Besides the use of different software algorithms and calculation techniques, a distinction between arteriolar, venular, and total FD should be made. All these variables in every stage toward data collection, analysis, and interpretation make it very hard to compare findings, which argues for the development of a study protocol based on comparative research, which is currently missing. Such standardization is indispensable to determine the position of FD analysis among other potential biomarkers. Additionally, many papers included in this review did not solely focus on FD, but explored a wide range of retinal vascular parameters (Tables 2, 3) without a detailed hypothesis. The comparison of many different parameters creates the problem of multiple comparisons and thus increases the likelihood of incorrectly rejecting a null hypothesis. However, only three out of 21 papers reported the use of correction (e.g., Bonferroni correction) to control for this type I error (Taylor et al., 2015; Jung et al., 2019; McGrory et al., 2019).
Future of Retinal Fractal Dimension: Limitations and Suggestions for Further Studies
There is a need for new, simple, non-invasive, cost-effective and reliable biomarkers for risk stratification, screening purposes, early diagnosis and follow-up in neurodegenerative disorders and stroke. Prevalence of neurodegenerative disease and stroke is increasing and causes an enormous socio-economic burden worldwide (Prince et al., 2015; Feigin et al., 2017). Diagnosis is often based on clinical symptoms complemented with technical investigations such as neuroimaging. However, diagnosis is often made at a point were irreversible damage has already occurred. On top of this, many diagnostic tests have the disadvantage of being costly, invasive and imperfect. State-of-the-art technologies for ocular imaging, such as spectral-domain optical coherence tomography (SD-OCT), OCT-A and SLO, allow to visualize retinal changes at a resolution of at least an order of a magnitude higher than conventional brain imaging techniques, without the need for invasive, costly procedures or tracers, and in a well-reproducible and quantifiable manner. These techniques are increasingly being implemented as standard equipment in ophthalmological and neurological practices. The assessment of the retinal FD, and possibly additional retinal vessel metrics, could find a way into clinical practice through these imaging techniques.
Besides standardization in the assessment of retinal FD in central neurodegeneration and stroke, in-depth knowledge about FD in health and disease is required to determine and consolidate the exact position of this parameter, e.g., in screening, risk stratification, early diagnosis, follow-up. Information on changes in FD in ocular and systemic conditions affecting the retinal vasculature needs to be supplemented to identify potential confounders. In diabetes mellitus, FD has been investigated extensively. Findings remain inconclusive, with a number of studies reporting an increased FD in patients with diabetes mellitus on one hand (Cheung et al., 2009; Lim et al., 2017; Orlando et al., 2017), and quite some studies describing a decreased FD in diabetes patients on the other hand (Avakian et al., 2002; Chen et al., 2018; Popovic et al., 2018). Inconsistencies can at least partly be explained by the wide variety in study methodology. In arterial hypertension, FD has been investigated less extensively, but studies tend to point toward a decreased FD in arterial hypertension (Liew et al., 2008; Cheung et al., 2011). A valuable population is that of “healthy” elderly, representing normal aging, including prevalent cardiovascular risk factors. Very little is known about the reversibility of FD changes, leaving the question whether lifestyle changes can “restore” FD unanswered. Another question that still remains is the exact temporal relationship between retinal and cerebral vascular changes. Prospective cohort studies with a standardized imaging and FD analysis protocol and long follow-up period can offer the answers to these questions and contribute to the understanding of the pathophysiology of neurodegenerative diseases and stroke.
This review provides a summary of the scientific literature regarding the association between retinal FD and neurodegenerative disease and stroke. Central nervous system disease is associated with a decreased FD, as a measure of microvascular network complexity. As retinal FD reflects the global integrity of the cerebral microvasculature (Cheung et al., 2015), it is an attractive parameter to explore. Most studies showed an association between retinal FD and neurodegeneration or stroke, but a predictive value has not been confirmed, partly due to its low specificity. The research community should strive for uniformization and standardization in retinal vessel analysis. Future research should also delineate the normal evolution of FD with age and cardiovascular health status to take the effect of confounders into account. This is required before the development of clinical applications for retinal FD can be established.
Data Availability Statement
All datasets generated for this study are included in the article/Supplementary Material.
SL: conception and design of study. SL, AD, and JB: acquisition, analysis of data, and drafting the manuscript. SL, KV, PD, and IS: revising the manuscript critically for important intellectual content. SL, AD, JB, KV, PD, and IS: approval of the version of the manuscript to be published.
SL has received a Ph.D. grant from VITO to perform a joint Ph.D. between VITO and UZ Leuven.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors wish to express their gratitude for the advice they received from Dr. Thomas Vandendriessche in building and refining the search strategy.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnins.2020.00016/full#supplementary-material
Ab+, beta-amyloid positive; Ab–, beta-amyloid negative; AD, Alzheimer's disease; ADCI, Alzheimer's disease cognitive impairment; AFa/v, arteriolar/venular asymmetry factor; AIBL, Australian Imaging, Biomarkers and Lifestyle; aMCI, amnestic mild cognitive impairment; AMT, Abbreviated Mental Test; AVR, artery-vein ratio; BAa/v, arteriolar/venular branching angle; BCa/v, arteriolar/venular branching coefficient; BCFDt, total box counting fractal dimension; BMES, Blue Mountains Eye Study; BSTDa/v, zone B standard deviation of arteriolar/venular width; CA, case; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CI, cognitive impairment; CIND, cognitive impairment no dementia; CMB, cerebral microbleeds; CO, control; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; CSVD, cerebral small vessel disease; CT, computed tomography; cTORTa/v, curvature arteriolar/venular tortuosity; DD, disc diameter; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders IV; DVP, deep vascular plexus; EDIS, Epidemiology of Dementia in Singapore; FD, fractal dimension; FDCt, total Higuchi's fractal dimension in circumferential direction; FDt/a/v, total/arteriolar/venular fractal dimension; FD0, capacity dimension (multifractal); FD1, information dimension (multifractal); FD2, correlation dimension (multifractal); FOV, field of view; IQ, intelligence quotient; IRIS-Fractal, International Retinal Imaging Software-Fractal; JEa/v, junctional exponent deviation for arterioles/venules; LBC1936, Lotharian Birth Cohort 1936; LDRa/v, arteriolar/venular length-diameter ratio; LI, lacunar infarction; LOE, level of evidence; M/F, male-female ratio; MCI, mild cognitive impairment; MCRS, Multi-Centre Retinal Stroke; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; MRI, magnetic resonance imaging; MSS, Mild Stroke Study; NCI, noncognitive impairment; NIA-AA, National Institute on Aging–Alzheimer's Association; NINCDS-ARDRA, National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; NS, not specified; Num1stBa/v, number of first branching arterioles/venules; OCT-A, optical coherence tomography angiography; OD, optic disc; PD, Parkinson's disease; RVN, retinal vascular network; RVP, retinal vascular parameters; SCES, Singapore Chinese Eye Study; SD, standard deviation; SD-OCT, spectral domain optical coherence tomography; SEED, Singapore Epidemiology of Eye Disease; SFDt, total spectrum (or Fourier) fractal dimension; SiMES, Singapore Malay Eye Study; SINDI, Singapore Indian Eye Study; SIVA, Singapore I Vessel Assessment; SLO, scanning laser ophthalmoscopy; sTORTa/v, simple arteriolar/venular tortuosity; SVaD, subcortical vascular dementia; SVCI, subcortical vascular cognitive impairment; svMCI, subcortical vascular mild cognitive impairment; SVP, superficial vascular plexus; T2DM, type 2 diabetes mellitus; TICSM, Telephone Interview for Cognitive Status; TOAST, Trial of Org 10172 in Acute Stroke Treatment; UWF, ultra-widefield; VAMPIRE, Vessel Assessment and Measurement Platform for Images of the Retina; WGa/v, arteriolar/venular width gradient; WHO-MONICA, World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease; WLCDTRU, West London Cognitive Disorders Treatment and Research Unit; WMH, white matter hyperintensity; WML, white matter lesions.
Ab Hamid, F., Che Azemin, M. Z., Salam, A., Aminuddin, A., Mohd Daud, N., and Zahari, I. (2016). Retinal vasculature fractal dimension measures vessel density. Curr. Eye Res. 41, 823–831. doi: 10.3109/02713683.2015.1056375
Aliahmad, B., Kumar, D. K., Hao, H., Unnikrishnan, P., Che Azemin, M. Z., Kawasaki, R., et al. (2014). Zone specific fractal dimension of retinal images as predictor of stroke incidence. ScientificWorldJournal 2014:467462. doi: 10.1155/2014/467462
Al-Sheikh, M., Iafe, N. A., Phasukkijwatana, N., Sadda, S. R., and Sarraf, D. (2018). Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography. Retina 38, 220–230. doi: 10.1097/IAE.0000000000001628
Al-Sheikh, M., Phasukkijwatana, N., Dolz-Marco, R., Rahimi, M., Iafe, N. A., Freund, K. B., et al. (2017). Quantitative OCT angiography of the retinal microvasculature and the choriocapillaris in myopic eyes. Invest. Ophthalmol. Vis. Sci. 58, 2063–2069. doi: 10.1167/iovs.16-21289
Avakian, A., Kalina, R. E., Sage, E. H., Rambhia, A. H., Elliott, K. E., Chuang, E. L., et al. (2002). Fractal analysis of region-based vascular change in the normal and non-proliferative diabetic retina. Curr. Eye Res. 24, 274–280. doi: 10.1076/ceyr.24.4.274.8411
Azemin, M. Z., Daud, N. M., Ab Hamid, F., Zahari, I., and Sapuan, A. H. (2014). Influence of refractive condition on retinal vasculature complexity in younger subjects. ScientificWorldJournal 2014:783525. doi: 10.1155/2014/783525
Azemin, M. Z., Kumar, D. K., Wong, T. Y., Kawasaki, R., Mitchell, P., and Wang, J. J. (2011). Robust methodology for fractal analysis of the retinal vasculature. IEEE Trans. Med. Imaging 30, 243–250. doi: 10.1109/TMI.2010.2076322
Azemin, M. Z., Kumar, D. K., Wong, T. Y., Wang, J. J., Mitchell, P., Kawasaki, R., et al. (2012). Age-related rarefaction in the fractal dimension of retinal vessel. Neurobiol. Aging. 33, 194.e1–4. doi: 10.1016/j.neurobiolaging.2010.04.010
Cabrera DeBuc, D., Somfai, G. M., Arthur, E., Kostic, M., Oropesa, S., and Mendoza Santiesteban, C. (2018). Investigating multimodal diagnostic eye biomarkers of cognitive impairment by measuring vascular and neurogenic changes in the retina. Front. Physiol. 9:1721. doi: 10.3389/fphys.2018.01721
Cavallari, M., Falco, T., Frontali, M., Romano, S., Bagnato, F., and Orzi, F. (2011). Fractal analysis reveals reduced complexity of retinal vessels in CADASIL. PLoS ONE 6:e19150. doi: 10.1371/journal.pone.0019150
Che Azemin, M. Z., Ab Hamid, F., Aminuddin, A., Wang, J. J., Kawasaki, R., and Kumar, D. K. (2013). Age-related rarefaction in retinal vasculature is not linear. Exp. Eye Res. 116, 355–358. doi: 10.1016/j.exer.2013.10.010
Chen, Q., Tan, F., Wu, Y., Zhuang, X., Wu, C., Zhou, Y., et al. (2018). Characteristics of retinal structural and microvascular alterations in early type 2 diabetic patients. Invest. Ophthalmol. Vis. Sci. 59, 2110–2118. doi: 10.1167/iovs.17-23193
Cheung, C. Y., Ong, S., Ikram, M. K., Ong, Y. T., Chen, C. P., Venketasubramanian, N., et al. (2014a). Retinal vascular fractal dimension is associated with cognitive dysfunction. J. Stroke Cerebrovasc. Dis. 23, 43–50. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.002
Cheung, C. Y., Ong, Y. T., Ikram, M. K., Ong, S. Y., Li, X., Hilal, S., et al. (2014b). Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimers Dementia 10, 135–142. doi: 10.1016/j.jalz.2013.06.009
Cheung, C. Y., Tay, W. T., Ikram, M. K., Ong, Y. T., De Silva, D. A., Chow, K. Y., et al. (2013). Retinal microvascular changes and risk of stroke: the singapore malay eye study. Stroke 44, 2402–2408. doi: 10.1161/STROKEAHA.113.001738
Cheung, C. Y., Tay, W. T., Mitchell, P., Wang, J. J., Hsu, W., Lee, M. L., et al. (2011). Quantitative and qualitative retinal microvascular characteristics and blood pressure. J. Hypertens. 29, 1380–1391. doi: 10.1097/HJH.0b013e328347266c
Cheung, N., Donaghue, K. C., Liew, G., Rogers, S. L., Wang, J. J., and Lim, S. W. (2009). Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care 32, 106–110. doi: 10.2337/dc08-1233
Csincsik, L., MacGillivray, T. J., Flynn, E., Pellegrini, E., Papanastasiou, G., Barzegar-Befroei, N., et al. (2018). Peripheral retinal imaging biomarkers for Alzheimer's disease: a pilot study. Ophthalmic Res. 59, 182–192. doi: 10.1159/000487053
Doubal, F. N., MacGillivray, T. J., Patton, N., Dhillon, B., Dennis, M. S., and Wardlaw, J. M. (2010). Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology. 74, 1102–1107. doi: 10.1212/WNL.0b013e3181d7d8b4
Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., et al. (2013). Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl. Psychiatry 3:e233. doi: 10.1038/tp.2012.150
Hilal, S., Ong, Y. T., Cheung, C. Y., Tan, C. S., Venketasubramanian, N., Niessen, W. J., et al. (2014). Microvascular network alterations in retina of subjects with cerebral small vessel disease. Neurosci. Lett. 577, 95–100. doi: 10.1016/j.neulet.2014.06.024
Huang, F., Dashtbozorg, B., Zhang, J., Bekkers, E., Abbasi-Sureshjani, S., Berendschot, T. T., et al. (2016). Reliability of using retinal vascular fractal dimension as a biomarker in the diabetic retinopathy detection. J. Ophthalmol. 2016:6259047. doi: 10.1155/2016/6259047
Hubbard, L. D., Brothers, R. J., King, W. N., Clegg, L. X., Klein, R., Cooper, L. S., et al. (1999). Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study. Ophthalmology 106, 2269–2280. doi: 10.1016/S0161-6420(99)90525-0
Jiang, H., Debuc, D. C., Rundek, T., Lam, B. L., Wright, C. B., Shen, M., et al. (2013). Automated segmentation and fractal analysis of high-resolution non-invasive capillary perfusion maps of the human retina. Microvasc. Res. 89, 172–175. doi: 10.1016/j.mvr.2013.06.008
Jiang, H., Wei, Y., Shi, Y., Wright, C. B., Sun, X., Gregori, G., et al. (2018). Altered macular microvasculature in mild cognitive impairment and Alzheimer disease. J. Neuroophthalmol. 38, 292–298. doi: 10.1097/WNO.0000000000000580
Jung, N. Y., Han, J. C., Ong, Y. T., Cheung, C. Y., Chen, C. P., Wong, T. Y., et al. (2019). Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease. J. Neurol. Sci. 396, 94–101. doi: 10.1016/j.jns.2018.10.025
Kawasaki, R., Che Azemin, M. Z., Kumar, D. K., Tan, A. G., Liew, G., Wong, T. Y., et al. (2011). Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study. Neurology 76, 1766–1767. doi: 10.1212/WNL.0b013e31821a7d7d
Li, H., Mitchell, P., Liew, G., Rochtchina, E., Kifley, A., Wong, T. Y., et al. (2010). Lens opacity and refractive influences on the measurement of retinal vascular fractal dimension. Acta Ophthalmol. 88, e234–e240. doi: 10.1111/j.1755-3768.2010.01975.x
Li, L. J., Lamoureux, E., Wong, T. Y., and Lek, N. (2017). Short-term poor glycemic control and retinal microvascular changes in pediatric type 1 diabetes patients in Singapore: a pilot study. BMC Ophthalmol. 17:60. doi: 10.1186/s12886-017-0449-8
Liew, G., Wang, J. J., Cheung, N., Zhang, Y. P., Hsu, W., Lee, M. L., et al. (2008). The retinal vasculature as a fractal: methodology, reliability, and relationship to blood pressure. Ophthalmology 115, 1951–1956. doi: 10.1016/j.ophtha.2008.05.029
Lim, L. S., Chee, M. L., Cheung, C. Y., and Wong, T. Y. (2017). Retinal vessel geometry and the incidence and progression of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 58, BIO200–BIO205. doi: 10.1167/iovs.17-21699
McGrory, S., Ballerini, L., Doubal, F. N., Staals, J., Allerhand, M., Valdes-Hernandez, M. D. C., et al. (2019). Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study. Sci. Rep. 9:6320. doi: 10.1038/s41598-019-42534-x
McGrory, S., Taylor, A. M., Pellegrini, E., Ballerini, L., Kirin, M., Doubal, F. N., et al. (2018). Towards standardization of quantitative retinal vascular parameters: comparison of SIVA and VAMPIRE measurements in the Lothian Birth Cohort 1936. Transl. Vis. Sci. Technol. 7:12. doi: 10.1167/tvst.7.2.12
Moher, D, Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 62, 1006–1012. doi: 10.1016/j.jclinepi.2009.06.005
Naidu, V. V., Ismail, K., Amiel, S., Kohli, R., Crosby-Nwaobi, R., Sivaprasad, S., et al. (2016). Associations between retinal markers of microvascular disease and cognitive impairment in newly diagnosed type 2 diabetes mellitus: a case control study. PLoS ONE 11:e0147160. doi: 10.1371/journal.pone.0147160
Ong, Y. T., De Silva, D. A., Cheung, C. Y., Chang, H. M., Chen, C. P., and Wong, M. C. (2013). Microvascular structure and network in the retina of patients with ischemic stroke. Stroke 44, 2121–2127. doi: 10.1161/STROKEAHA.113.001741
Ong, Y. T., Hilal, S., Cheung, C. Y., Xu, X., Chen, C., and Venketasubramanian, N. (2014). Retinal vascular fractals and cognitive impairment. Dement. Geriatr. Cogn. Dis. Extra 4, 305–313. doi: 10.1159/000363286
Orlando, J. I., van Keer, K., Barbosa Breda, J., Manterola, H. L., Blaschko, M. B., and Clausse, A. (2017). Proliferative diabetic retinopathy characterization based on fractal features: evaluation on a publicly available dataset. Med. Phys. 44, 6425–6434. doi: 10.1002/mp.12627
Patton, N., Pattie, A., MacGillivray, T., Aslam, T., Dhillon, B., Gow, A., et al. (2007). The association between retinal vascular network geometry and cognitive ability in an elderly population. Invest. Ophthalmol. Vis. Sci. 48, 1995–2000. doi: 10.1167/iovs.06-1123
Pellegrini, E., Robertson, G., Trucco, E., MacGillivray, T. J., Lupascu, C., van Hemert, J., et al. (2014). Blood vessel segmentation and width estimation in ultra-wide field scanning laser ophthalmoscopy. Biomed. Opt. Express. 5:4329–4337. doi: 10.1364/BOE.5.004329
Phillips, B. (2014). Oxford Centre for Evidence-Based Medicine – Levels of Evidence. Centre for Evidence Based Medicine. Available online at: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
Popovic, N., Radunovic, M., Badnjar, J., and Popovic, T. (2018). Fractal dimension and lacunarity analysis of retinal microvascular morphology in hypertension and diabetes. Microvasc. Res. 118, 36–43. doi: 10.1016/j.mvr.2018.02.006
Prince, M., Wimo, A., Guerchet, M., Ali, G. C., Wu, Y. T., and Prina, M. (2015). The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends. London: Alzheimer's Disease International.
Shi, C., Chen, Y., Kwapong, W. R., Tong, Q., Wu, S., Zhou, Y., et al. (2019). Characterization by fractal dimension analysis of the retinal capillary network in Parkinson disease. Retina. doi: 10.1097/IAE.0000000000002641. [Epub ahead of print].
Soares, J. V., Leandro, J. J., Cesar Júnior, R. M., Jelinek, H. F., and Cree, M. J. (2006). Retinal vessel segmentation using the 2-D Gabor wavelet and supervised classification. IEEE Trans. Med. Imaging. 25, 1214–1222. doi: 10.1109/TMI.2006.879967
Stanley, H. E., Buldyrev, S. V., Goldberger, A. L., Havlin, S., Mantegna, R. N., Ossadnik, S. M., et al. (2005). “Fractals in biology and medicine,” in Diffusion Processes: Experiment, Theory, Simulations.
Tai, E. L., Li, L. J., Wan-Hazabbah, W. H., Wong, T. Y., and Shatriah, I. (2017). Effect of axial eye length on retinal vessel parameters in 6 to 12-year-old Malay girls. PLoS ONE 12:e0170014. doi: 10.1371/journal.pone.0170014
Taylor, A. M., MacGillivray, T. J., Henderson, R. D., Ilzina, L., Dhillon, B., Starr, J. M., et al. (2015). Retinal vascular fractal dimension, childhood iq, and cognitive ability in old age: the Lothian birth cohort study 1936. PLoS ONE 10:e0121119. doi: 10.1371/journal.pone.0121119
Wei, Y., Jiang, H., Shi, Y., Qu, D., Gregori, G., Zheng, F., et al. (2017). Age-related alterations in the retinal microvasculature, microcirculation, and microstructure. Invest. Ophthalmol. Vis. Sci. 58, 3804–3817. doi: 10.1167/iovs.17-21460
Williams, M. A., McGowan, A. J., Cardwell, C. R., Cheung, C. Y., Craig, D., Passmore, P., et al. (2015). Retinal microvascular network attenuation in Alzheimer's disease. Alzheimers Dementia 1, 229–235. doi: 10.1016/j.dadm.2015.04.001
Wu, R., Cheung, C. Y., Saw, S. M., Mitchell, P., Aung, T., and Wong, T. Y. (2013). Retinal vascular geometry and glaucoma: the Singapore Malay Eye Study. Ophthalmology 120, 77–83. doi: 10.1016/j.ophtha.2012.07.063
Keywords: fractal dimension, retina, brain, neurodegeneration, cognitive impairment, Alzheimer's disease, stroke, cerebral small vessel disease
Citation: Lemmens S, Devulder A, Van Keer K, Bierkens J, De Boever P and Stalmans I (2020) Systematic Review on Fractal Dimension of the Retinal Vasculature in Neurodegeneration and Stroke: Assessment of a Potential Biomarker. Front. Neurosci. 14:16. doi: 10.3389/fnins.2020.00016
Received: 14 November 2019; Accepted: 08 January 2020;
Published: 28 January 2020.
Edited by:Silvia Di Angelantonio, Sapienza University of Rome, Italy
Reviewed by:Delia Cabrera DeBuc, University of Miami, United States
M. Heather West Greenlee, Iowa State University, United States
Copyright © 2020 Lemmens, Devulder, Van Keer, Bierkens, De Boever and Stalmans. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sophie Lemmens, email@example.com